FIELD: medicine; endocrinology; therapy; dietetics.
SUBSTANCE: invention can be used to assess the likelihood of carbohydrate metabolism disorders in individuals aged from 45 to 59 years. If the patient’s waist circumference is between 100.70 and 105.70 cm, the sleep duration is between 5.9 and 6.1 hours, triglyceride level is between 1.30 and 1.85 mmol/L, homocysteine level is between 9.23 up to 10.18 mcmol/l, platelet aggregation activity is from 36.70 to 47.44%, interleukin-6 level in the blood is from 5.1 to 8.9 pg/ml, daily range of body temperature is from 0.23 to 0.53 degrees Celsius, the daily amplitude of glycemia is from 0.28 to 0.97 mmol/l, then the probability of carbohydrate metabolism disorders is 81.5%.
EFFECT: method provides the ability to assess the likelihood of carbohydrate metabolism disorders in individuals with obesity and desynchronosis by determining the duration of sleep, the average level of triglycerides, homocysteine, platelet aggregation activity and interleukin-6 in the blood, the daily amplitude of body temperature and glycemia.
1 cl, 2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR TREATING PREDIABETES IN PERSONS WITH EXTERNAL EATING BEHAVIOR | 2022 |
|
RU2805361C1 |
METHOD FOR PREDICTION OF RISK OF DEVELOPING VASCULAR LESIONS AT EARLY STAGES OF CARBOHYDRATE METABOLISM DISORDERS | 2019 |
|
RU2735706C1 |
METHOD OF TREATING METABOLIC SYNDROME | 2015 |
|
RU2583944C1 |
METHOD OF TREATING METABOLIC SYNDROME IN EMOTIOGENIC TYPE OF EATING BEHAVIOUR | 2015 |
|
RU2591811C1 |
METHOD FOR ASSESSING GLYCEMIC VARIABILITY TO DETERMINE EFFECTIVENESS OF ANTIHYPERGLYCEMIC THERAPY IN PATIENTS WITH MODY2 DIABETES | 2020 |
|
RU2746830C1 |
METHOD OF TREATING PATIENTS WITH DYSPEPSIA SYNDROME COMBINED WITH OVERWEIGHT | 2012 |
|
RU2528641C2 |
METHOD FOR COMPLEX TREATMENT OF METABOLIC SYNDROME | 2015 |
|
RU2616125C1 |
DIAGNOSTIC TECHNIQUE FOR CLINICALLY LATENT HYPERCORTICOIDISM IN PATIENTS SUFFERING FROM STYPE 2 DIABETES MELLITUS OR OBESITY | 2012 |
|
RU2521387C1 |
METHOD OF DIAGNOSING PRECLINICAL FORMS OF CARBOHYDRATE METABOLISM DISORDERS | 1997 |
|
RU2140204C1 |
METHOD FOR MONITORING INDIVIDUALS WITH RISK OF EARLY ATHEROSCLEROSIS AND SUFFERING FROM TYPE 2 DIABETES MELLITUS | 2013 |
|
RU2533836C1 |
Authors
Dates
2023-12-05—Published
2023-07-19—Filed